The FDA issued an RFI seeking venture capital input on a new contract model to connect portfolio companies directly with ...
A massive recall was issued for products that could result in serious illness "due to adulteration from pests, including ...
The FDA is expected to decide on treatments for breast cancer, EBV+ post-transplant lymphoproliferative disease, focal segmental glomerulosclerosis, presbyopia, and severe allergic reactions.
Poherdy can be dispensed as a substitute for Perjeta without requiring a prescription change from a health care provider.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback